Featuring perspectives from Dr Thomas E Hutson, Dr Rana R McKay, Dr Sumanta Kumar Pal and Dr Tian Zhang, moderated by Dr Pal, including the following topics:
- Introduction (0:00)
- Immunotherapeutic Strategies for Localized and Metastatic Clear Cell Renal Cell Carcinoma (RCC) — Dr Hutson (2:34)
- Optimal Management of Relapsed/Refractory RCC — Dr Zhang (32:49)
- Role of HIF-2α Inhibitors in the Treatment of Sporadic and von Hippel-Lindau-Associated RCC — Dr McKay (1:04:02)
- Current and Future Care of Patients with Non-Clear Cell RCC — Dr Pal (1:33:13)
CME information and select publications